This series aims to provide five bitesize-talks in current areas of trial methodology which would be of interest to researchers wanting to improve the quality and efficiency of trial design. The sessions will cover biomarker trial design and justification for sample collection, the choice of endpoints as well as co-primary and composite endpoints, and an introduction to phase II designs. The speakers are senior methodologists who are all members of CTRad’s workstreams. Each session will consist of a 15-minute talk followed by Q&A for up to 15 minutes:

  • 24 February 2021 – Methodological justification for sample collections – Chris Hurt, Cardiff University (recording available)
  • 24 March 2021 – Biomarker trial design – Dr Sarah Brown, University of Leeds (recording available)
  • 28 April 2021 – Choosing an endpoint – Professor Emma Hall, The Institute of Cancer Research (recording available)
  • 26 May 2021 – Coprimary and composite endpoints – Jo Haviland, The Institute of Cancer Research (recording available)
  • 23 June 2021 – Phase II designs – Lucy McParland, PHASTAR

Who should attend?
Researchers who are interested in gaining an introduction to aspects of trial methodology.


Jun 23 2021


12:30 pm - 1:00 pm